Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1997; 30:847-854
© 1997 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Almagor, Y
Right arrow Articles by Leon, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Almagor, Y
Right arrow Articles by Leon, M.

First international new intravascular rigid-flex endovascular stent study (FINESS): clinical and angiographic results after elective and urgent stent implantation. The FINESS Trial Investigators

Y Almagor, S Feld, F Kiemeneij, PW Serruys, MC Morice, A Colombo, C Macaya, JL Guermonprez, J Marco, R Erbel, IM Penn, R Bonan, and MB Leon

Shaare Zedek Medical Center, Jerusalem, Israel. cardio@szmc.org.il

OBJECTIVES: The purpose of this study was to determine the feasibility, safety and efficacy of elective and urgent deployment of the new intravascular rigid-flex (NIR) stent in patients with coronary artery disease. BACKGROUND: Stent implantation has been shown to be effective in the treatment of focal, new coronary stenoses and in restoring coronary flow after coronary dissection and abrupt vessel closure. However, currently available stents either lack flexibility, hindering navigation through tortuous arteries, or lack axial strength, resulting in suboptimal scaffolding of the vessel. The unique transforming multicellular design of the NIR stent appears to provide both longitudinal flexibility and radial strength. METHODS: NIR stent implantation was attempted in 255 patients (341 lesions) enrolled prospectively in a multicenter international registry from December 1995 through March 1996. Nine-, 16- and 32-mm long NIR stents were manually crimped onto coronary balloons and deployed in native coronary (94%) and saphenous vein graft (6%) lesions. Seventy-four percent of patients underwent elective stenting for primary or restenotic lesions, 21% for a suboptimal angioplasty result and 5% for threatened or abrupt vessel closure. Fifty-two percent of patients presented with unstable angina, 48% had a previous myocardial infarction, and 45% had multivessel disease. Coronary lesions were frequently complex, occurring in relatively small arteries (mean [+/-SD] reference diameter 2.8 +/- 0.6 mm). Patients were followed up for 6 months for the occurrence of major adverse cardiovascular events. RESULTS: Stent deployment was accomplished in 98% of lesions. Mean minimal lumen diameter increased by 1.51 +/- 0.51 mm (from 1.09 +/- 0.43 mm before to 2.60 +/- 0.50 mm after the procedure). Mean percent diameter stenosis decreased from 61 +/- 13% before to 17 +/- 7% after intervention. A successful interventional procedure with < 50% diameter stenosis of all treatment site lesions and no major adverse cardiac events within 30 days occurred in 95% of patients. Event-free survival at 6 months was 82%. Ninety-four percent of surviving patients were either asymptomatic or had mild stable angina at 6 month follow-up. CONCLUSIONS: Despite unfavorable clinical and angiographic characteristics of the majority of patients enrolled, the acute angiographic results and early clinical outcome after NIR stent deployment were very promising. A prospective, randomized trial comparing the NIR stent with other currently available stents appears warranted.


This article has been cited by other articles:


Home page
Diabetes and Vascular Disease ResearchHome page
C. Hage, A. Norhammar, L. Grip, K. Malmberg, N. Sarkar, B. Svane, and L. Ryden
Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study
Diabetes and Vascular Disease Research, April 1, 2009; 6(2): 71 - 79.
[Abstract] [PDF]


Home page
CirculationHome page
P. V. Oemrawsingh, G. S. Mintz, M. J. Schalij, A. H. Zwinderman, J. W. Jukema, and E. E.v.d. Wall
Intravascular Ultrasound Guidance Improves Angiographic and Clinical Outcome of Stent Implantation for Long Coronary Artery Stenoses: Final Results of a Randomized Comparison With Angiographic Guidance (TULIP Study)
Circulation, January 7, 2003; 107(1): 62 - 67.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. J. Cantor, E. D. Peterson, J. J. Popma, J. P. Zidar, M. H. Sketch Jr., J. E. Tcheng, and E. M. Ohman
Provisional stenting strategies: systematic overview and implications for clinical decision-making
J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1142 - 1151.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
H. W. ROBERTS and S. W. REDDING
CORONARY ARTERY STENTS: REVIEW AND PATIENT-MANAGEMENT RECOMMENDATIONS
J Am Dent Assoc, June 1, 2000; 131(6): 797 - 801.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Kobayashi, J. De Gregorio, N. Kobayashi, T. Akiyama, B. Reimers, L. Finci, C. Di Mario, and A. Colombo
Stented segment length as an independent predictor of restenosis
J. Am. Coll. Cardiol., September 1, 1999; 34(3): 651 - 659.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C di Mario, B Reimers, Y Almagor, I Moussa, L Di Francesco, M Ferraro, M B Leon, K Richter, and A Colombo
Procedural and follow up results with a new balloon expandable stent in unselected lesions
Heart, March 1, 1998; 79(3): 234 - 241.
[Abstract] [Full Text]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement